INTRODUCTION
============

Acute exposure to high altitude occurs when a person who lives below 2,000 meters above sea level (m.a.s.l.) is exposed to an altitude above 2,000 m.a.s.l. At night, mountaineers exposed to hypobaric hypoxia (HH) may present respiratory disorders. As described by Angelo Mosso in 1898-through simple observation of his brother's breathing pattern during sleep-high-altitude, PB is the most commonly detected^[@r1]^. Even though PB may occur above 2,000 m.a.s.l., it prevails above 5,000 m.a.s.l.^[@r2]^.

The characteristics of high-altitude PB may differ from semiological descriptions based on data from patients with cardiovascular or neurologic disease, but existing data are scarce^[@r2]^. Additionally, there is scant evidence on the effect of acclimatization and no data on the effects of gradual ascent on the semiology of breathing patterns during an expedition.

In order to analyze respiratory cycle alterations during sleep at high altitude and describe temporary changes or changes observed at different levels, we took objective measurements of the breathing patterns of the members of an expedition to Mount Aconcagua. Mountaineers were healthy physicians who volunteered to take part in this study, in context of a mountain medicine course.

MATERIALS AND METHODS
=====================

This was a prospective study on a database made up of systematically collected data from healthy mountaineers who voluntarily enrolled in this study. We conducted a descriptive study using RP recordings obtained at night at different altitudes during the ascent of Mount Aconcagua: 746 m.a.s.l. (Mendoza City-baseline), 2581 m.a.s.l. (Penitentes), 3200 m.a.s.l. (Las Cuevas), 3300 m.a.s.l. (Confluencia), 4300 m.a.s.l. (Plaza de Mulas), 4900m.a.s.l. (Plaza Canadá), 5380 m.a.s.l. (Nido de Cóndores). The expedition, which was part of a research study conducted during a course on Mountain Medicine, left on January 29 and returned on February 15, 2016.

Population
----------

Eight healthy mountaineers volunteered to take part in the study (2 physicians who are experienced mountaineers and acted as guides, and 6 physicians who are non-professional mountaineers). They had no history of respiratory disorders.

Respiratory Polygraphy
----------------------

Polygraphic parameters, such as nasal airflow, thoracic effort with qualitative band, and oximetry (average signal time \< 1 second) were measured with level III portable monitors of the American Academy of Sleep Medicine^[@r3]^; Apnea Link Plus^®^(ResMed. Sydney. Australia) with finger pulse oximeter (XPod^®^, Nonin. USA).

All study subjects were trained in the use of polygraphy devices before the ascent. The strategy used during the expedition was self-administered testing^[@r4]^. Subjects ascended the mountain together. The entire expedition lasted 17 days (Mendoza-Mendoza).

Respiratory polygraphy recordings were obtained at night in shelters (baseline and lower altitude sites: Penitentes and Las Cuevas), in dome tent shelters (located at the intermediate-altitude campsites known as Confluencia and Plaza de Mulas) and in subjects' tents (in high-altitude campsites known as Plaza Canadá and Nido de Cóndores).

Data obtained from RP recordings were downloaded using specific software and a portable computer. Later, at the Sleep Disorders Unit of Buenos Aires' Hospital Británico, recordings were edited and analyzed manually (*sequential manual scoring*) using Apnea Link^®^ 9.0 software. Only recordings with \> 4 hours of good quality signal over total recording time (TRT)-after edition-were accepted. Manual edition of events was carried out by pulmonologists trained in AASM current standards^[@r3],[@r4]^.

Apneas and hypopneas were defined as respiratory events with a \> 90% and \> 50% reduction in nasal airflow, respectively, associated to a = 3% drop in oxygen saturation for at least 10 seconds^[@r4]^.

AHI was defined as the number of respiratory events (apneas + hypopneas) over valid TRT. After final scoring, recordings were classified either as normal (AHI \< 5/h), mild (AHI between 6 and 14.9 events per hour), moderate (AHI between 15 and 29.9/hour), or severe (AHI \> 30/hour). ODI was also calculated over TRT, and the desaturation threshold (90% - 85% and 80%) was measured in minutes and as a percentage of valid TRT. ODI was defined as 3% desaturation with respect to the immediately preceding baseline value. Severity categories were the same as those defined for AHI (mild, moderate, and severe).

High-altitude periodic breathing (PB) was identified when the typical polypnea/apnea or crescendo-decrescendo pattern was registered for at least 2 hours of TRT^[@r4]^.

In high-altitude PB, we measured cycle duration (from the onset of an apnea event to the beginning of the next event, or from the top of the diamond-like shape in the flow signal to the top of the next one). Analyzed data included 20 measurements in equally set pages with good quality signal (5-10 minutes). Findings were averaged out in seconds. Finally, the hyperventilation/apnea or hypoventilation phase (when appropriate) was calculated with regard to total cycle duration (Duty Cycle) as a substitute for Edwards and Sands' loop gain^[@r2],[@r5]^.

Statistical Analysis
--------------------

Results were expressed as mean value, standard error, range or percentage. P value (*p*) \< 0.05 was regarded as a statistically significant difference. Investigators used Kruskal-Wallis and Dunn's multiple comparison tests. Tukey test was used to compare multiple measurements.

RESULTS
=======

Four men and four women took part in the study. Mean age was 36 years old (25-51); BMI at baseline and at the end of the expedition was 23.6 (20.9-28.7) and 22.8 (20.9-27.7) respectively (*p* \< 0.01).

Forty three sleep polygraphy tests provided valid recordings, four had to be rejected due to a total recording time \< 4 hours (TRT: \< 240 minutes).

Study findings showed that the apnea-hypopnea-index (AHI) increased with altitude at the expense of central apneas and hypopneas; *p* \< 0.05. The increase in obstructive apneas was not significant ([Figure 1](#f1){ref-type="fig"}).

Figure 1Increase in AHI observed at higher altitudes. Gradual increase in the number of central apneas and hypopneas with regard to altitude above sea level. Note the marked increase in the number of events recorded above 4300 m.a.s.l. relationship between obstructive apneas and height (not statiscally significant).

ODI increased at the last two levels ([Figure 2](#f2){ref-type="fig"}) *p* \< 0.05 and ST~80~ was the only indicator that showed an elevated correlation; *r*: 0.85 (CI: 0.71 - 0.93) *p* \< 0.01, with altitude reached.

Figure 2Oxygen desaturation index (ODI) per hour; 3% threshhold with regard to ascent.

The incidence of high-altitude PB was 44.2% (19/43) in the polygraphy recordings of our mountaineers. None of the mountaineers showed PB at baseline; however, high-altitude PB occurred in all subjects above 4,900 m.a.s.l.-the mean height of occurrence being 4,130 (2581-5380 m.a.s.l.)

Moreover, with regard to TRT (PB/TRTx100), high-altitude PB represented 30.9% and increased with height. PB time represented 23.5% of TRT at Penitentes (2581 m.a.s.l.), Las Cuevas (3200 m.a.s.l. included Confluencia 3300 m.a.s.l.), 32% at Plaza de Mulas (4300 m.a.s.l.) and 38.3% at the highest altitudes reached (Plaza Canada -4900- and Nido de Cóndores -5380-) ([Figure 3](#f3){ref-type="fig"}).

Figure 3PB identified during ascent to higher altitudes above sea level. The PB is not evident in the basal polygraphy recording (746 msnm), increases with height and is evident in all of them at high altitude (\> 4900 m.a.s.l.).

In mountaineers with frequent acute exposure to high altitude (guides), PB/TRTx100 was 12.6%. The rest of the group (sporadic acute exposure) showed PB/TRTx100 of 39.7% (*p* \> 0.05). High-altitude PB occurred as apnea/polypnea or increasing decreasing with hypopnea.

Guides (2 andinist) presented mainly an increasing-decreasing cycle with 7-11 breaths in the hyperventilation phase. For the rest of the group, high-altitude PB was marked by central apneas and 3-4 breaths in the polypnea phase of the cycle with a wider range of desaturations.

The duration of the high-altitude PB cycle (mean value) was 24.2 (SD: 3.8) seconds both when subjects presented crescendo-decrescendo patterns ([Figure 4a](#f4){ref-type="fig"}) or the typical central apneas with mean hyperventilation/apnea ratio of 0.47 ([Figure 4b](#f4){ref-type="fig"}). Recordings without high-altitude PB showed lower ODI: 5.43 (range: 0 - 20) *versus* 45.9 (2-122) *p* \< 0.001) and mean AHI values: 3.9 (0-15.5) *versus* 44.35 (4-115) *p* \< 0.001), respectively.

Figure 4A. Increasing / decreasing PB with hypopnea, B. apnea/hyperpnoea PB with apnea central.

The mean Duty Cycle values measured individually during the ascent did not show any significant differences.

DISCUSSION
==========

According to most authors, PB is the respiratory event most frequently observed at high altitudes. In general, it occurs above 2000 m.a.s.l.^[@r6]^ and presents a characteristic hyperpnoea/apnea phase^[@r2],[@r4],[@r6]^, as we also observed. In our experience, PB is not evident in the basal polygraphy recording (746 m.a.s.l.), increases with height and is evident in all of them at high altitude (\> 4900 m.a.s.l.).

In spite of the low number of participants, as is usual in high-altitude expeditions^[@r3]^, we were able to perform many polygraphy tests so as to assess PB at different altitudes.

Differences found in the morphology of high-altitude PB in mountain guides and non-professional mountaineers could be related to the acclimatization process through frequent exposure to high altitude and respiratory centers with an altered physiological response to recent HH. We obtained measurements at different altitudes and observed no changes in Duty Cycle or cycle duration during ascent.

This is one of the main differences between our study and other published works that refer only to the hyperpnoea/apnea^[@r2],[@r7]^ cycle recordings or compare altitude findings with a preceding baseline value. However, since our measurements lack neurophysiological signals to define "sleep" (electroencephalogram), our findings may be underestimated^[@r4]^.

The cycle of high-altitude PB is \< 30 seconds, unlike heart failure-related PB, described as 59±4.9 seconds and central or primary PB 37.3±3 seconds with 4.5±0.7 cycle seconds^[@r4],[@r8]^. In our recordings, these cycles were remarkably shorter (24 seconds in average), as in other similarly designed fieldworks^[@r2],[@r9]^. Short cycles, as compared to heart failure or idiopathic periodic breathing (IPB), are an important condition in high-altitude PB, even when our recordings presented a curved morphology with two patterns, as in PB.

It is worth highlighting that the recommended definition of PB in polysomnographic recordings^[@r4]^ does not exactly apply to high-altitude PB, because of cycle duration criteria. There is no universal definition of high-altitude PB for polygraphy test measurements.

There are two mechanisms that may account for high-altitude PB: ventilatory response to hypoxia and carbon dioxide threshold (CO~2~). At high altitude, HH produces initial response, tachypnea and polypnea that lead to a drop in CO~2~ and an increased heart rate. The increased blood flow to the brain related with hyperventilation leads to low arterial CO~2~ during sleep, the respiratory center has a higher CO~2~ threshold that leads to apnea, rapidly increasing the concentration of CO~2~. Compensating polypnea is the response to this rapid increase in CO~2~. Typical PB occurs because inhalation of CO~2~ at high altitude only eliminates apnea but not periodicity, which is eliminated with oxygen supply^[@r5],[@r10]^. With gradual ascent, especially at extreme altitudes (4900 and 5380 m.a.s.l. in our experience), The PB is not evident in the basal polygraphs (746 m.a.s.l.), increases with height and is evident in all of them at high altitude (\> 4900 m.a.s.l.) [Figure 3](#f3){ref-type="fig"}.

AHI increases at the expense of central apneas ([Figure 1b](#f1){ref-type="fig"}) due to typical high-altitude PB ([Figure 4 A](#f4){ref-type="fig"}) and, to a lesser degree, hypopneas ([Figure 1c](#f1){ref-type="fig"}).

Our conclusions, however, are limited by the fact that we lack objective CO~2~ measurements.

In frequent or recent HH exposure (mountain guides), acclimatization of the respiratory center and peripheral chemoreceptors affected by CO~2~ variations from previous exposure would respond differently with increasing/decreasing patterns without apnea. Response to CO~2~ would be more compliant to hypoxia, which would favor high altitude PB^[@r2],[@r9]^. However, the characteristics of Duty Cycle as a substitute for loop gain did not change in our study subjects.

CONCLUSIONS
===========

Above 2581 m.a.s.l., high-altitude PB and central apneas were frequent findings in healthy mountaineers. Subjects with frequent acute exposure presented fewer central apneas with increasing/decreasing cycles and hypopneas and similar duration cycles.

The characteristics of high-altitude PB differ from idiopathic and heart failure-related PB, since high-altitude PB presents shorter cycles.
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